David Moradi's Net Worth
$13.7 Million
Who is David Moradi?
David Moradi has an estimated net worth of $13.7 Million. This is based on reported shares across multiple companies, which include KALOBIOS PHARMACEUTICALS INC, and AUDIOEYE INC.
SEC CIK
David Moradi's CIK is 0001658843
Past Insider Trading and Trends
2021 was David Moradi's most active year for acquiring shares with 13 total transactions. David Moradi's most active month to acquire stocks was the month of July. 2019 was David Moradi's most active year for disposing of shares, totalling 6 transactions. David Moradi's most active month to dispose stocks was the month of July. 2019 saw David Moradi paying a total of $1,616,982.06 for 2,013,663 shares, this is the most they've acquired in one year. In 2021 David Moradi cashed out on 70,251 shares for a total of $398,422.86, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AUDIOEYE INC (AEYE) Snapshot price: $5.11
CHIEF EXECUTIVE OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.04% | 29.95K |
$5.59 | $167,355.81 | 2.9M |
Sep 15
| |||
Form 4
| +0.16% | 4.46K |
$5.55 | $24,737.24 | 2.87M |
Mar 17
| |||
Form 4
| +0.22% | 6.34K |
$5.44 | $34,470.51 | 2.86M |
Mar 15 - Mar 16
| |||
Form 4
| -3.29% | -29.32K |
$3.84 | -$112,694.55 | 862.91K |
Jan 20
| |||
Form 4
| +81.26% | 400K |
—
|
—
| 892.22K |
May 20
| |||
Form 4
| +1.76% | 49.36K |
$7.77 | $383,299.43 | 2.86M |
Nov 30 - Dec 2
| |||
Form 4
| +0.96% | 26.73K |
$11.46 | $306,268.93 | 2.81M |
Aug 19 - Aug 20
| |||
Form 4
| +1.84% | 50.23K |
$10.69 | $537,161.90 | 2.78M |
Aug 16 - Aug 18
| |||
Form 4
| +39.63% | 153.89K |
—
|
—
| 542.22K |
May 24
| |||
Form 4
| +14.78% | 50K |
—
|
—
| 388.33K |
Mar 11
| |||
Form 4
| -3.49% | -12.25K |
$15.39 | -$373,422.86 | 338.33K |
Jan 15 - Feb 18
| |||
Form 4
| +79.25% | 155K |
—
|
—
| 350.59K |
Aug 20
| |||
Form 4
| +5.67% | 146.67K |
$6.00 | $880,002.00 | 2.73M |
Aug 11
| |||
Form 4
| +17.51% | 29.14K |
—
|
—
| 195.59K |
May 20
| |||
Form 4
| +7.27% | 11.28K |
—
|
—
| 166.45K |
Dec 6
| |||
Form 4
| +56.01% | 927.86K |
$1.74 | $1,616,982.06 | 2.58M |
Aug 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KALOBIOS PHARMACEUTICALS INC (HGEN) Snapshot price: $0.0002
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +1.95% | 6.82K |
$29.32 | $199,962.40 | 356.42K |
Dec 16
| |||
Form 4
| +0.91% | 6.82K |
$29.32 | $199,962.40 | 756.42K |
Dec 16
| |||
Form 4
| +35.31% | 300K |
$2.13 | $639,000.00 | 1.15M |
Nov 18
| |||
Form 4/A
| +525.29% | 713.73K |
$1.42 | $1,014,262.76 | 849.6K |
Nov 16 - Nov 17
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||